44 related articles for article (PubMed ID: 1300128)
1. Bioavailability study of furosemide prodrugs in rats.
Prandi C; Fagiolino P; Manta E; Dominguez Llera L
Farmaco; 1992 Sep; 47(9):1225-34. PubMed ID: 1300128
[TBL] [Abstract][Full Text] [Related]
2. Development of absorption furosemide prodrugs: synthesis, in vitro and in vivo evaluation.
Prandi C; Fagiolino P; Manta E; Llera LD; Aiache JM; Couquelet J
Farmaco; 1992 Feb; 47(2):249-63. PubMed ID: 1510797
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability and pharmacokinetics of furosemide marketed in Thailand.
Kaojarern S; Poobrasert O; Utiswannakul A; Kositchaiwat U
J Med Assoc Thai; 1990 Apr; 73(4):191-7. PubMed ID: 2394955
[TBL] [Abstract][Full Text] [Related]
5. Inclusion complexation of furosemide in cyclodextrins. Part 2: Implication on bioavailability.
Ammar HO; Ghorab M; Emara LH; el-Nahhas SA; Makram TS
Pharmazie; 1999 Mar; 54(3):207-10. PubMed ID: 10192107
[TBL] [Abstract][Full Text] [Related]
6. Variable furosemide absorption and poor predictability of response in elderly patients.
Murray MD; Haag KM; Black PK; Hall SD; Brater DC
Pharmacotherapy; 1997; 17(1):98-106. PubMed ID: 9017769
[TBL] [Abstract][Full Text] [Related]
7. Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay.
Smith DE; Lin ET; Benet LZ
Drug Metab Dispos; 1980; 8(5):337-42. PubMed ID: 6107232
[TBL] [Abstract][Full Text] [Related]
8. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
Fukano Y; Kawazu K
Drug Metab Dispos; 2009 Aug; 37(8):1622-34. PubMed ID: 19477946
[TBL] [Abstract][Full Text] [Related]
9. Aminocarbonyloxymethyl ester prodrugs of flufenamic acid and diclofenac: suppressing the rearrangement pathway in aqueous media.
Ribeiro L; Silva N; Iley J; Rautio J; Järvinen T; Mota-Filipe H; Moreira R; Mendes E
Arch Pharm (Weinheim); 2007 Jan; 340(1):32-40. PubMed ID: 17206608
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of furosemide urinary elimination by nephrotic children.
Prandota J
Pediatr Res; 1983 Feb; 17(2):141-7. PubMed ID: 6828331
[TBL] [Abstract][Full Text] [Related]
11. Existence of a flip-flop kinetic model for zidovudine (AZT) after oral administration.
Melvin GC; Ellison SR; Monk CM; Bates TR
Res Commun Chem Pathol Pharmacol; 1990 Nov; 70(2):193-204. PubMed ID: 2277865
[TBL] [Abstract][Full Text] [Related]
12. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic evaluation of (-)-6-aminocarbovir as a prodrug for (-)-carbovir in rats.
Zimmerman CL; Remmel RP; Ibrahim SS; Beers SA; Vince R
Drug Metab Dispos; 1992; 20(1):47-51. PubMed ID: 1346995
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro and in vivo characterization of novel ethyl dioxy phosphate prodrug of propofol.
Kumpulainen H; Järvinen T; Mannila A; Leppänen J; Nevalainen T; Mäntylä A; Vepsäläinen J; Rautio J
Eur J Pharm Sci; 2008 Jul; 34(2-3):110-7. PubMed ID: 18403185
[TBL] [Abstract][Full Text] [Related]
15. Glyceride derivatives as potential prodrugs: synthesis, biological activity and kinetic studies of glyceride derivatives of mefenamic acid.
Khan MS; Akhter M
Pharmazie; 2005 Feb; 60(2):110-4. PubMed ID: 15739898
[TBL] [Abstract][Full Text] [Related]
16. Two absorption furosemide prodrugs.
Mombrú AW; Mariezcurrena RA; Suescun L; Pardo H; Manta E; Prandi C
Acta Crystallogr C; 1999 Mar; 55 ( Pt 3)():413-6. PubMed ID: 10220870
[TBL] [Abstract][Full Text] [Related]
17. Determination of bioequivalence of two furosemide preparations; the effect of high doses of furosemide on some pharmacokinetic parameters.
Wolf-Coporda A; Lovrić Z; Huić M; Francetić I; Vrhovac B; Plavsić F; Skreblin M
Int J Clin Pharmacol Res; 1996; 16(4-5):83-8. PubMed ID: 9172005
[TBL] [Abstract][Full Text] [Related]
18. Absorption and enterohepatic circulation of baicalin in rats.
Xing J; Chen X; Zhong D
Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
[TBL] [Abstract][Full Text] [Related]
19. Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability.
Yan L; Müller CE
J Med Chem; 2004 Feb; 47(4):1031-43. PubMed ID: 14761205
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of ascorbic acid enhancement of the bioavailability and diuretic effect of furosemide.
Lee MG; Chiou WL
Drug Metab Dispos; 1998 May; 26(5):401-7. PubMed ID: 9571221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
